Organon & Co. (OGN)
13.78
+0.03
(+0.22%)
USD |
NYSE |
Oct 28, 16:00
13.79
+0.01
(+0.07%)
Pre-Market: 20:00
Organon Price to Book Value : 3.597 for Oct. 28, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 28, 2026 | 3.597 |
| October 27, 2026 | 3.589 |
| October 26, 2026 | 3.587 |
| October 23, 2026 | 3.589 |
| October 22, 2026 | 3.589 |
| October 21, 2026 | 3.589 |
| October 20, 2026 | 3.592 |
| October 19, 2026 | 3.589 |
| October 16, 2026 | 3.592 |
| October 15, 2026 | 3.592 |
| October 14, 2026 | 3.587 |
| October 13, 2026 | 3.595 |
| October 12, 2026 | 3.595 |
| October 09, 2026 | 3.605 |
| October 08, 2026 | 3.589 |
| October 07, 2026 | 3.600 |
| October 06, 2026 | 3.587 |
| October 05, 2026 | 3.576 |
| October 02, 2026 | 3.582 |
| October 01, 2026 | 3.579 |
| September 30, 2026 | 3.576 |
| September 29, 2026 | 3.587 |
| September 28, 2026 | 3.584 |
| September 25, 2026 | 3.584 |
| September 24, 2026 | 3.582 |
| Date | Value |
|---|---|
| September 23, 2026 | 3.584 |
| September 22, 2026 | 3.576 |
| September 21, 2026 | 3.571 |
| September 18, 2026 | 3.571 |
| September 17, 2026 | 3.574 |
| September 16, 2026 | 3.568 |
| September 15, 2026 | 3.566 |
| September 14, 2026 | 3.563 |
| September 11, 2026 | 3.561 |
| September 10, 2026 | 3.558 |
| September 09, 2026 | 3.568 |
| September 08, 2026 | 3.589 |
| September 04, 2026 | 3.597 |
| September 03, 2026 | 3.595 |
| September 02, 2026 | 3.595 |
| September 01, 2026 | 3.592 |
| August 31, 2026 | 3.592 |
| August 28, 2026 | 3.592 |
| August 27, 2026 | 3.592 |
| August 26, 2026 | 3.595 |
| August 25, 2026 | 3.589 |
| August 24, 2026 | 3.589 |
| August 21, 2026 | 3.589 |
| August 20, 2026 | 3.587 |
| August 19, 2026 | 3.584 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Viatris, Inc. | 1.521 |
| Pacira Biosciences, Inc. | 2.156 |
| Bristol Myers Squibb Co. | 5.544 |
| Harmony Biosciences Holdings, Inc. | 2.239 |
| ANI Pharmaceuticals, Inc. | 2.758 |
Price to Book Value Related Metrics
| PE Ratio | 17.65 |
| PS Ratio | 0.5927 |
| Price to Free Cash Flow | 6.508 |
| Price | 13.78 |
| Earnings Yield | 5.66% |
| Market Cap | 3.619B |
| Operating PE Ratio | 3.054 |
| Normalized PE Ratio | 9.105 |